Biogtuss TR is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Advanced Generic Corporation. The primary component is Guaifenesin; Phenylephrine Hydrochloride; Dextromethorphan Hydrobromide.
| Product ID | 45737-605_678a8e9a-7480-4fbe-ad80-4907383b59c8 |
| NDC | 45737-605 |
| Product Type | Human Otc Drug |
| Proprietary Name | Biogtuss TR |
| Generic Name | Guaifenesin, Phenylephrine Hcl, Dextromethorphan Hbr |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-04-01 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | Advanced Generic Corporation |
| Substance Name | GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE |
| Active Ingredient Strength | 388 mg/1; mg/1; mg/1 |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2014-04-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2014-04-01 |
| Inactivation Date | 2019-11-27 |
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 388 mg/1 |
| SPL SET ID: | bdc5b26f-bb43-4a5e-ac00-5bae1414c3e5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |